Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has received a request from a promoter group member to reclassify their shareholding from 'Promoter Group' to 'Public' category under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has received a request from a promoter group member to reclassify their shareholding from 'Promoter Group' to 'Public' category under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has received requests from four promoter group members to reclassify themselves as public category shareholders under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The requests are subject to consideration and approval by the Board of Directors, Stock Exchanges, and other applicable conditions.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has received requests from two promoter group members to reclassify themselves from the 'Promoter Group' category to the 'Public' category of shareholders under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the acceptance/rejection of securities for dematerialisation during the quarter ended September 30, 2026.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange regarding 'Extinguishment of Equity Shares'. The company has extinguished 8,88,296 (Eight Lakh Eighty Eight Thousand and Two Hundred and Ninety Six) fully paid-up Equity Shares of the face value ₹ 2/- each (Rupees Two only) of Advanced Enzyme Technologies Limited (“Company”) consequent to the ongoing buyback from the open market route through the Stock Exchanges.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has received a revised request from a promoter group member, Radhika Ashish Pujara, to reclassify from the 'Promoter Group' category to the 'Public' category under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will remain closed from October 01, 2026, till 48 hours after the announcement of the Company's financial results for the quarter and half year ended September 30, 2026.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has received revised requests from some promoter group members to reclassify themselves from Promoter Group to Public category shareholders under SEBI regulations.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about a special window for transfer and dematerialization of physical shares, as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has extinguished 8,25,028 equity shares bought back during the month of August 2026 through the open market route.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has received requests from five promoter group members to reclassify from the 'Promoter Group' category to the 'Public' category under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The requests are subject to consideration and approval by the Board of Directors and other applicable conditions.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about the transcript of the conference call held on August 12, 2026, for the unaudited financial results for the quarter ended June 30, 2026.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about General Updates related to the buyback of equity shares using the open market purchase through Stock Exchanges. The company has certified compliance with SEBI regulations and will maintain compliance during the buyback process.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about the link of recording of the conference call for the unaudited financial results for the quarter ended June 30, 2026, which is available on the company's website.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has submitted the Exchange the Board Resolution of Buyback, approving the buyback of up to 10% of the paid-up capital and free reserves of the Company through the open market route.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has announced a buyback of its equity shares from the open market through stock exchanges under the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended. The buyback will open on August 14, 2026, and will end on the earlier of November 20, 2026, or when the company completes the buyback by deploying the amount equivalent to the Maximum Buyback Size.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about Copy of Newspaper Publication regarding Extract of Unaudited Consolidated Financial Results for the quarter ended June 30, 2026.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about Investor Presentation, enclosed is the Earnings Presentation for the quarter ended June 30, 2026. Revenue grew by 2% on y-o-y basis to ₹ 1,859 million in Q1 FY27 from ₹ 1,859 million in Q1 FY26. EBITDA de-grew by 10% to ₹ 510 million in Q1 FY27 from ₹ 632 million in Q4 FY26. PAT decreased to ₹ 386 million in Q1 FY27 from ₹ 453 million in Q4 FY26.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has announced its unaudited financial results for the first quarter ended June 2026, with revenue from operations growing by 2% year-on-year to ₹1,898 million and EBITDA margin standing at 27%. The company's profit after tax de-grew by 5% to ₹386 million, and earnings per share stood at ₹3.31.